vs

Side-by-side financial comparison of LEE ENTERPRISES, Inc (LEE) and MEDIFAST INC (MED). Click either name above to swap in a different company.

LEE ENTERPRISES, Inc is the larger business by last-quarter revenue ($130.1M vs $75.1M, roughly 1.7× MEDIFAST INC). On growth, LEE ENTERPRISES, Inc posted the faster year-over-year revenue change (-10.0% vs -36.9%). LEE ENTERPRISES, Inc produced more free cash flow last quarter ($3.7M vs $-6.6M). Over the past eight quarters, LEE ENTERPRISES, Inc's revenue compounded faster (-5.8% CAGR vs -34.4%).

Lee Enterprises, Inc. is a publicly traded American media company. It publishes 72 daily newspapers in 25 states, and more than 350 weekly, classified, and specialty publications. Lee Enterprises was founded in 1890 by Alfred Wilson Lee and is based in Davenport, Iowa.

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

LEE vs MED — Head-to-Head

Bigger by revenue
LEE
LEE
1.7× larger
LEE
$130.1M
$75.1M
MED
Growing faster (revenue YoY)
LEE
LEE
+26.9% gap
LEE
-10.0%
-36.9%
MED
More free cash flow
LEE
LEE
$10.3M more FCF
LEE
$3.7M
$-6.6M
MED
Faster 2-yr revenue CAGR
LEE
LEE
Annualised
LEE
-5.8%
-34.4%
MED

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
LEE
LEE
MED
MED
Revenue
$130.1M
$75.1M
Net Profit
$-5.6M
Gross Margin
69.4%
Operating Margin
4.0%
-10.4%
Net Margin
-4.3%
Revenue YoY
-10.0%
-36.9%
Net Profit YoY
66.5%
EPS (diluted)
$-0.92
$-1.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LEE
LEE
MED
MED
Q4 25
$130.1M
$75.1M
Q3 25
$139.1M
$89.4M
Q2 25
$141.3M
$105.6M
Q1 25
$137.4M
$115.7M
Q4 24
$144.6M
$119.0M
Q3 24
$158.6M
$140.2M
Q2 24
$150.6M
$168.6M
Q1 24
$146.6M
$174.7M
Net Profit
LEE
LEE
MED
MED
Q4 25
$-5.6M
Q3 25
$-6.4M
$-2.3M
Q2 25
$-1.9M
$2.5M
Q1 25
$-12.5M
$-772.0K
Q4 24
$-16.7M
Q3 24
$-10.1M
$1.1M
Q2 24
$-4.3M
$-8.2M
Q1 24
$-12.2M
$8.3M
Gross Margin
LEE
LEE
MED
MED
Q4 25
69.4%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
Q3 24
75.4%
Q2 24
73.2%
Q1 24
72.8%
Operating Margin
LEE
LEE
MED
MED
Q4 25
4.0%
-10.4%
Q3 25
-1.0%
-4.6%
Q2 25
3.3%
-1.0%
Q1 25
-3.3%
-1.1%
Q4 24
-2.3%
0.6%
Q3 24
-2.3%
1.5%
Q2 24
3.3%
-4.7%
Q1 24
-3.1%
4.5%
Net Margin
LEE
LEE
MED
MED
Q4 25
-4.3%
Q3 25
-4.6%
-2.5%
Q2 25
-1.4%
2.3%
Q1 25
-9.1%
-0.7%
Q4 24
-11.6%
Q3 24
-6.4%
0.8%
Q2 24
-2.8%
-4.8%
Q1 24
-8.3%
4.8%
EPS (diluted)
LEE
LEE
MED
MED
Q4 25
$-0.92
$-1.64
Q3 25
$-1.02
$-0.21
Q2 25
$-0.31
$0.22
Q1 25
$-2.07
$-0.07
Q4 24
$-2.80
$0.08
Q3 24
$-1.68
$0.10
Q2 24
$-0.73
$-0.75
Q1 24
$-2.06
$0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LEE
LEE
MED
MED
Cash + ST InvestmentsLiquidity on hand
$12.6M
$167.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$-48.7M
$198.9M
Total Assets
$592.6M
$248.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LEE
LEE
MED
MED
Q4 25
$12.6M
$167.3M
Q3 25
$10.0M
$173.5M
Q2 25
$14.1M
$162.7M
Q1 25
$4.7M
$164.6M
Q4 24
$6.1M
$162.3M
Q3 24
$9.6M
$170.0M
Q2 24
$13.4M
$163.5M
Q1 24
$16.1M
$156.4M
Stockholders' Equity
LEE
LEE
MED
MED
Q4 25
$-48.7M
$198.9M
Q3 25
$-43.3M
$214.7M
Q2 25
$-40.5M
$216.0M
Q1 25
$-38.9M
$211.0M
Q4 24
$-26.7M
$210.1M
Q3 24
$-9.9M
$207.3M
Q2 24
$4.0M
$205.3M
Q1 24
$7.9M
$211.0M
Total Assets
LEE
LEE
MED
MED
Q4 25
$592.6M
$248.0M
Q3 25
$601.7M
$268.2M
Q2 25
$622.7M
$269.3M
Q1 25
$623.9M
$280.0M
Q4 24
$633.0M
$284.2M
Q3 24
$649.2M
$291.2M
Q2 24
$677.5M
$293.5M
Q1 24
$684.8M
$302.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LEE
LEE
MED
MED
Operating Cash FlowLast quarter
$4.5M
$-5.3M
Free Cash FlowOCF − Capex
$3.7M
$-6.6M
FCF MarginFCF / Revenue
2.9%
-8.8%
Capex IntensityCapex / Revenue
0.6%
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.5M
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LEE
LEE
MED
MED
Q4 25
$4.5M
$-5.3M
Q3 25
$-6.3M
$12.1M
Q2 25
$8.9M
$-3.4M
Q1 25
$-790.0K
$3.4M
Q4 24
$-7.3M
$-4.9M
Q3 24
$-261.0K
$9.1M
Q2 24
$-1.9M
$13.1M
Q1 24
$3.2M
$7.3M
Free Cash Flow
LEE
LEE
MED
MED
Q4 25
$3.7M
$-6.6M
Q3 25
$-8.3M
$10.8M
Q2 25
$8.3M
$-4.8M
Q1 25
$-2.2M
$1.9M
Q4 24
$-8.9M
$-7.2M
Q3 24
$-2.9M
$7.7M
Q2 24
$-5.5M
$11.1M
Q1 24
$1.3M
$5.4M
FCF Margin
LEE
LEE
MED
MED
Q4 25
2.9%
-8.8%
Q3 25
-6.0%
12.0%
Q2 25
5.9%
-4.5%
Q1 25
-1.6%
1.6%
Q4 24
-6.1%
-6.1%
Q3 24
-1.8%
5.5%
Q2 24
-3.6%
6.6%
Q1 24
0.9%
3.1%
Capex Intensity
LEE
LEE
MED
MED
Q4 25
0.6%
1.8%
Q3 25
1.4%
1.5%
Q2 25
0.4%
1.3%
Q1 25
1.0%
1.3%
Q4 24
1.1%
1.9%
Q3 24
1.7%
1.0%
Q2 24
2.4%
1.1%
Q1 24
1.3%
1.1%
Cash Conversion
LEE
LEE
MED
MED
Q4 25
Q3 25
Q2 25
-1.36×
Q1 25
Q4 24
Q3 24
8.04×
Q2 24
Q1 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LEE
LEE

Advertising And Marketing Services$60.0M46%
Subscription And Circulation$57.7M44%
Other$12.4M10%

MED
MED

Segment breakdown not available.

Related Comparisons